Cannabis and Schizophrenia: Meta-Analysis Finds Roughly Threefold Risk Elevation, but Causation Remains Contested
The cannabis schizophrenia risk meta-analysis reveals a significant association between cannabis use and increased schizophrenia risk. This risk is especially pronounced with adolescent use and high-THC products. However, causation remains contested due…
Cannabinoids Show Promise for Chronic Pain, But Evidence Remains Thin
The cannabinoids chronic pain evidence review reveals moderate efficacy signals across several conditions but highlights the low quality of current studies. While cannabinoids show promise, the evidence remains thin due to small sample sizes and short…
Cannabis Users Need More Propofol, But Confounders Cloud the Evidence
Cannabis anesthesia requirements are increasingly relevant as cannabis use rises among surgical patients. This meta-analysis finds cannabis users require more propofol, but confounders like age and tobacco use complicate interpretation. Understanding…
Medical Cannabis for Chronic Pain: Promise, Pharmacology, and Persistent Gaps
This 2025 medical cannabis chronic pain review examines the pharmacology and clinical evidence for cannabinoids in pain management. While promising, significant gaps remain in standardized dosing and long-term safety data. The review highlights the need…
Cannabinoids for Postoperative Pain: A Systematic Review Finds Too Little Evidence to Draw Firm Conclusions
This systematic review examines cannabinoids postoperative pain evidence and finds insufficient data to support their use for acute postoperative pain. Only five randomized controlled trials were identified, with contradictory results. The review…
What the Evidence Actually Says About Cannabis: Risks, Benefits, and Lingering Uncertainties
Cannabis use disorder research reveals significant health risks and modest medical benefits. This 2024 review examines cognitive impairment and psychiatric risks linked to cannabis. Understanding these findings helps inform clinical practice and patient…
Research Digest: 4 Recent Studies – April 09, 2026
This research digest presents 4 recent cannabis research studies curated for clinical relevance and evidence quality. Each study offers insights into cannabis effects, safety, and psychiatric associations. Stay informed with this April 2026 update on…
Critical Review of Cannabis Contaminant Testing and Regulatory Oversight
Cannabis contaminant testing regulations vary widely across states, impacting product safety and consumer protection. This review highlights inconsistencies in testing standards and analytical methods. Understanding these regulations is critical for…
Daily Anxiety and Depressive Symptoms Linked to Cannabis-Alcohol Co-Use
Daily anxiety cannabis alcohol co-use is strongly linked to mental health symptoms among Black sexual and gender minority people. This study highlights the increased risk of same-day co-use compared to single-substance use. Understanding these patterns…
Effect of Cannabinol, THCV, and CBD on Voluntary Alcohol Consumption
This study investigates how cannabis compounds reduce alcohol consumption by influencing the endocannabinoid system. Cannabinol, tetrahydrocannabivarin, and cannabidiol were tested for their effects on voluntary alcohol intake. These findings highlight…